The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?

Neurochemistry International

Volumn 99, Issue , 2016, Pages 110-132

  Stilling, Roman M ^a,b   van de Wouw, Marcel ^a,b   Clarke, Gerard ^a,b   Stanton, Catherine ^a,c   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Endocrine; Gut brain axis; Neuroepigenetics; Nutrition; Sociability; Treg

Indexed keywords

BUTYRIC ACID; CELL RECEPTOR; HISTONE; LYSINE; MONOCARBOXYLATE TRANSPORTER; SHORT CHAIN FATTY ACID; VOLATILE FATTY ACID; BUTYRIC ACID DERIVATIVE;

BEHAVIOR; BIOCHEMISTRY; BRAIN FUNCTION; DIET; HISTONE ACETYLATION; HUMAN; IMMUNE SYSTEM; INTERPERSONAL COMMUNICATION; INTESTINE FLORA; LONG TERM MEMORY; MENTAL DISEASE; MICROBIOME; NEUROLOGIC DISEASE; NEUROPHARMACOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; ANIMAL; BRAIN; DAIRY PRODUCT; DRUG EFFECTS; ENERGY METABOLISM; GASTROINTESTINAL TRACT; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; BUTYRATES; DAIRY PRODUCTS; ENERGY METABOLISM; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS;

EID: 84977109277     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2016.06.011     Document Type: Review

References (248)

1. Adipietro, K.A., Mainland, J.D., Matsunami, H., Functional evolution of mammalian odorant receptors. PLoS Genet., 8, 2012, 10.1371/journal.pgen.1002821.
2. Aitoro, R., Paparo, L., Costanzo, M.D., Nocerino, R., Amoroso, A., Amato, F., Pirozzi, C., Calignano, A., Meli, R., Simeoli, R., Nagler, C., Guandalini, S., Berni, C., Breast milk butyrate as protective factor against food allergy. Dig. Liver Dis., 47, 2015, e274, 10.1016/j.dld.2015.07.150.
3. Ang, Z., Ding, J.L., GPR41 and GPR43 in obesity and inflammation – protective or causative?. Front. Immunol., 7, 2016, 10.3389/fimmu.2016.00028.
4. Artis, D., Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8 (2008), 411–420, 10.1038/nri2316.
5. Astbury, S., Corfe, B.M., Uptake and metabolism of the short-chain fatty acid butyrate, a critical review of the literature. Curr. Drug Metab. 13 (2012), 815–821, 10.2174/138920012800840428.
6. Bach Knudsen, K.E., Serena, A., Canibe, N., Juntunen, K.S., New insight into butyrate metabolism. Proc. Nutr. Soc. 62 (2003), 81–86, 10.1079/PNS2002212.
7. Baeza, J., Smallegan, M.J., Denu, J.M., Mechanisms and dynamics of protein acetylation in mitochondria. Trends Biochem. Sci., 2016, 10.1016/j.tibs.2015.12.006.
8. Barcenilla, A., Pryde, S.E., Martin, J.C., Duncan, S.H., Stewart, C.S., Henderson, C., Flint, H.J., Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 66 (2000), 1654–1661.
9. Belenguer, A., Duncan, S.H., Calder, A.G., Holtrop, G., Louis, P., Lobley, G.E., Flint, H.J., Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 72 (2006), 3593–3599, 10.1128/AEM.72.5.3593-3599.2006.
10. Bergersen, L., Rafiki, A., Ottersen, O.P., Immunogold cytochemistry identifies specialized membrane domains for monocarboxylate transport in the central nervous system. Neurochem. Res. 27 (2002), 89–96.
11. Biagi, E., Candela, M., Turroni, S., Garagnani, P., Franceschi, C., Brigidi, P., Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol. Res. SI Hum. microbiome health 69 (2013), 11–20, 10.1016/j.phrs.2012.10.005.
12. Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., Brigidi, P., De Vos, W., Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5, 2010, e10667, 10.1371/journal.pone.0010667.
13. Bindelle, J., Buldgen, A., Leterme, P., Nutritional and environmental consequences of dietary fibre in pig nutrition: a review. Base 12 (2008), 69–80.
14. Boehm, T., Zufall, F., MHC peptides and the sensory evaluation of genotype. Trends Neurosci. 29 (2006), 100–107, 10.1016/j.tins.2005.11.006.
15. Bollrath, J., Powrie, F., Feed your tregs more fiber. Science 341 (2013), 463–464, 10.1126/science.1242674.
16. Bolognini, D., Tobin, A.B., Milligan, G., Moss, C.E., The pharmacology and function of receptors for short-chain fatty acids. Mol. Pharmacol. 89 (2016), 388–398, 10.1124/mol.115.102301.
17. Bordin, M., D'Atri, F., Guillemot, L., Citi, S., Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol. Cancer Res. MCR 2 (2004), 692–701.
18. Borthakur, A., Saksena, S., Gill, R.K., Alrefai, W.A., Ramaswamy, K., Dudeja, P.K., Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway. J. Cell. Biochem. 103 (2008), 1452–1463, 10.1002/jcb.21532.
19. Bourassa, M.W., Alim, I., Bultman, S.J., Ratan, R.R., Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health?. Neurosci. Lett., 2016, 10.1016/j.neulet.2016.02.009.
20. Brandl, A., Heinzel, T., Krämer, O.H., Histone deacetylases: salesmen and customers in the post-translational modification market. Biol. Cell Auspices Eur. Cell Biol. Organ 101 (2009), 193–205, 10.1042/BC20080158.
21. Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Guan, N.L., Kundu, P., Gulyás, B., Halldin, C., Hultenby, K., Nilsson, H., Hebert, H., Volpe, B.T., Diamond, B., Pettersson, S., The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med., 6, 2014, 10.1126/scitranslmed.3009759 263ra158.
22. Brennan, P.A., Kendrick, K.M., Mammalian social odours: attraction and individual recognition. Philos. Trans. R. Soc. B Biol. Sci. 361 (2006), 2061–2078, 10.1098/rstb.2006.1931.
23. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., Muir, A.I., Wigglesworth, M.J., Kinghorn, I., Fraser, N.J., Pike, N.B., Strum, J.C., Steplewski, K.M., Murdock, P.R., Holder, J.C., Marshall, F.H., Szekeres, P.G., Wilson, S., Ignar, D.M., Foord, S.M., Wise, A., Dowell, S.J., The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278 (2003), 11312–11319, 10.1074/jbc.M211609200.
24. Brown, R.E., Schellinck, H.M., Interactions among the MHC, diet and bacteria in the production of social odors in rodents. Doty, R.L., Müller-Schwarze, D., (eds.) Chemical Signals in Vertebrates 6, 1992, Springer US, 175–181.
25. Byrne, C.S., Chambers, E.S., Morrison, D.J., Frost, G., The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. 39 (2015), 1331–1338, 10.1038/ijo.2015.84.
26. Canani, R.B., Costanzo, M.D., Leone, L., Pedata, M., Meli, R., Calignano, A., Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. WJG 17 (2011), 1519–1528, 10.3748/wjg.v17.i12.1519.
27. Candido, E.P., Reeves, R., Davie, J.R., Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14 (1978), 105–113.
28. Castellucci, V.F., Blumenfeld, H., Goelet, P., Kandel, E.R., Inhibitor of protein synthesis blocks long-term behavioral sensitization in the isolated gill-withdrawal reflex of Aplysia. J. Neurobiol. 20 (1989), 1–9, 10.1002/neu.480200102.
29. Chen, H., Assmann, J.C., Krenz, A., Rahman, M., Grimm, M., Karsten, C.M., Köhl, J., Offermanns, S., Wettschureck, N., Schwaninger, M., Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. J. Clin. Invest. 124 (2014), 2188–2192, 10.1172/JCI72151.
30. Chen, H.-L., Cheng, H.-C., Wu, W.-T., Liu, Y.-J., Liu, S.-Y., Supplementation of konjac glucomannan into a low-fiber Chinese diet promoted bowel movement and improved colonic ecology in constipated adults: a placebo-controlled, diet-controlled trial. J. Am. Coll. Nutr. 27 (2008), 102–108.
31. Chen, P.S., Wang, C.-C., Bortner, C.D., Peng, G.-S., Wu, X., Pang, H., Lu, R.-B., Gean, P.-W., Chuang, D.-M., Hong, J.-S., Valproic acid and other hdac inhibitors induce microglial apoptosis and attenuate lipopolysaccharide- induced dopaminergic neurotoxicity. Neuroscience 149 (2007), 203–212, 10.1016/j.neuroscience.2007.06.053.
32. Chomiak, T., Turner, N., Hu, B., What we have learned about autism spectrum disorder from valproic acid. Pathol. Res. Int., 2013, 2013, 712758, 10.1155/2013/712758.
33. Chou, A.-H., Chen, S.-Y., Yeh, T.-H., Weng, Y.-H., Wang, H.-L., HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3. Neurobiol. Dis. 41 (2011), 481–488, 10.1016/j.nbd.2010.10.019.
34. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M.L., Rehman, M., Walther, T.C., Olsen, J.V., Mann, M., Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325 (2009), 834–840, 10.1126/science.1175371.
35. Clarke, G., Stilling, R.M., Kennedy, P.J., Stanton, C., Cryan, J.F., Dinan, T.G., Minireview: gut microbiota: the neglected endocrine organ. Mol. Endocrinol. Balt. Md 28 (2014), 1221–1238, 10.1210/me.2014-1108.
36. Cleophas, M.C.P., Crişan, T.O., Lemmers, H., Toenhake-Dijkstra, H., Fossati, G., Jansen, T.L., Dinarello, C.A., Netea, M.G., Joosten, L.A.B., Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann. Rheum. Dis. 75 (2016), 593–600, 10.1136/annrheumdis-2014-206258.
37. Collins, M.D., Lawson, P.A., Willems, A., Cordoba, J.J., Fernandez-Garayzabal, J., Garcia, P., Cai, J., Hippe, H., Farrow, J.A., The phylogeny of the genus clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44 (1994), 812–826, 10.1099/00207713-44-4-812.
38. Collins, S.M., Surette, M., Bercik, P., The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10 (2012), 735–742, 10.1038/nrmicro2876.
39. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13 (2012), 701–712, 10.1038/nrn3346.
40. Cuff, M.A., Lambert, D.W., Shirazi-Beechey, S.P., Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol. 539 (2002), 361–371.
41. Cummings, J.H., Macfarlane, G.T., Englyst, H.N., Prebiotic digestion and fermentation. Am. J. Clin. Nutr. 73 (2001), 415s–420s.
42. Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P., Macfarlane, G.T., Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 (1987), 1221–1227.
43. Dale, N., Kandel, E.R., Schacher, S., Serotonin produces long-term changes in the excitability of Aplysia sensory neurons in culture that depend on new protein synthesis. J. Neurosci. Off. J. Soc. Neurosci. 7 (1987), 2232–2238.
44. Davie, J.R., Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133 (2003), 2485S–2493S.
45. den Besten, G., van Eunen, K., Groen, A.K., Venema, K., Reijngoud, D.-J., Bakker, B.M., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54 (2013), 2325–2340, 10.1194/jlr.R036012.
46. de Theije, C.G.M., Koelink, P.J., Korte-Bouws, G.A.H., Lopes da Silva, S., Korte, S.M., Olivier, B., Garssen, J., Kraneveld, A.D., Intestinal inflammation in a murine model of autism spectrum disorders. Brain. Behav. Immun. 37 (2014), 240–247, 10.1016/j.bbi.2013.12.004.
47. de Theije, C.G.M., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., Kraneveld, A.D., Oozeer, R., Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain. Behav. Immun. 37 (2014), 197–206, 10.1016/j.bbi.2013.12.005.
48. De Vuyst, L., Leroy, F., Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int. J. Food Microbiol. 149 (2011), 73–80, 10.1016/j.ijfoodmicro.2011.03.003 3rd International Symposium on Propionibacteria and Bifidobacteria: Dairy and Probiotic applications, Oviedo 1-4 June 2010.
49. Di Sabatino, A., Morera, R., Ciccocioppo, R., Cazzola, P., Gotti, S., Tinozzi, F.P., Tinozzi, S., Corazza, G.R., Oral butyrate for mildly to moderately active Crohn's disease. Aliment. Pharmacol. Ther. 22 (2005), 789–794, 10.1111/j.1365-2036.2005.02639.x.
50. Duncan, S.H., Holtrop, G., Lobley, G.E., Calder, A.G., Stewart, C.S., Flint, H.J., Contribution of acetate to butyrate formation by human faecal bacteria. Br. J. Nutr. 91 (2004), 915–923, 10.1079/BJN20041150.
51. Duncan, S.H., Louis, P., Flint, H.J., Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70 (2004), 5810–5817, 10.1128/AEM.70.10.5810-5817.2004.
52. Duncan, S.H., Louis, P., Thomson, J.M., Flint, H.J., The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 11 (2009), 2112–2122, 10.1111/j.1462-2920.2009.01931.x.
53. Egorin, M.J., Yuan, Z.M., Sentz, D.L., Plaisance, K., Eiseman, J.L., Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother. Pharmacol. 43 (1999), 445–453, 10.1007/s002800050922.
54. El Aidy, S., Dinan, T.G., Cryan, J.F., Immune modulation of the brain-gut-microbe axis. Front. Microbiol., 5, 2014, 146, 10.3389/fmicb.2014.00146.
55. Erny, D., Hrabě de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E., Garrett, W.S., McCoy, K.D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I., Prinz, M., Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18 (2015), 965–977, 10.1038/nn.4030.
56. Ewaschuk, J.B., Naylor, J.M., Zello, G.A., D-lactate in human and ruminant metabolism. J. Nutr. 135 (2005), 1619–1625.
57. Fallingborg, J., Intraluminal pH of the human gastrointestinal tract. Dan. Med. Bull. 46 (1999), 183–196.
58. Fazzalari, F.A., (eds.) Compilation of Odor and Taste Threshold Values Data, 1978, ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428–2959.
59. Febo, M., Akbarian, S., Schroeder, F.A., Ferris, C.F., Cocaine-induced metabolic activation in cortico-limbic circuitry is increased after exposure to the histone deacetylase inhibitor, sodium butyrate. Neurosci. Lett. 465 (2009), 267–271, 10.1016/j.neulet.2009.07.065.
60. Fernandes, J., Su, W., Rahat-Rozenbloom, S., Wolever, T.M.S., Comelli, E.M., Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr. Diabetes, 4, 2014, e121, 10.1038/nutd.2014.23.
61. Ferrante, R.J., Kubilus, J.K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N.W., Ratan, R.R., Luthi-Carter, R., Hersch, S.M., Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. Off. J. Soc. Neurosci. 23 (2003), 9418–9427.
62. Filiano, A.J., Gadani, S.P., Kipnis, J., Interactions of innate and adaptive immunity in brain development and function. Brain Res. 1617 (2015), 18–27, 10.1016/j.brainres.2014.07.050.
63. Fischer, A., Sananbenesi, F., Mungenast, A., Tsai, L.-H., Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci. 31 (2010), 605–617, 10.1016/j.tips.2010.09.003.
64. Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., Tsai, L.-H., Recovery of learning and memory is associated with chromatin remodelling. Nature 447 (2007), 178–182, 10.1038/nature05772.
65. Flint, H.J., Duncan, S.H., Scott, K.P., Louis, P., Interactions and competition within the microbial community of the human colon: links between diet and health. Environ. Microbiol. 9 (2007), 1101–1111, 10.1111/j.1462-2920.2007.01281.x.
66. Forsythe, P., Bienenstock, J., Kunze, W.A., Vagal pathways for microbiome-brain-gut axis communication. Lyte, M., Cryan, J.F., (eds.) Microbial Endocrinology: the Microbiota-gut-brain Axis in Health and Disease, Advances in Experimental Medicine and Biology, 2014, Springer New York, 115–133.
67. Franceschi, C., Bonafè, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., De Benedictis, G., Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908 (2000), 244–254.
68. Frey, U., Morris, R.G., Synaptic tagging and long-term potentiation. Nature 385 (1997), 533–536, 10.1038/385533a0.
69. Fukumoto, S., Tatewaki, M., Yamada, T., Fujimiya, M., Mantyh, C., Voss, M., Eubanks, S., Harris, M., Pappas, T.N., Takahashi, T., Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003), R1269–R1276, 10.1152/ajpregu.00442.2002.
70. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K., Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450, 10.1038/nature12721.
71. Fu, S.-P., Liu, B.-R., Wang, J.-F., Xue, W.-J., Liu, H.-M., Zeng, Y.-L., Huang, B.-X., Li, S.-N., Lv, Q.-K., Wang, W., Liu, J.-X., β-Hydroxybutyric acid inhibits growth hormone-releasing hormone synthesis and secretion through the GPR109A/extracellular signal-regulated 1/2 signalling pathway in the hypothalamus. J. Neuroendocrinol. 27 (2015), 212–222, 10.1111/jne.12256.
72. Gagliano, H., Delgado-Morales, R., Sanz-Garcia, A., Armario, A., High doses of the histone deacetylase inhibitor sodium butyrate trigger a stress-like response. Neuropharmacology 79 (2014), 75–82, 10.1016/j.neuropharm.2013.10.031.
73. Gallagher, M., Wysocki, C.J., Leyden, J.J., Spielman, A.I., Sun, X., Preti, G., Analyses of volatile organic compounds from human skin. Br. J. Dermatol. 159 (2008), 780–791, 10.1111/j.1365-2133.2008.08748.x.
74. Ganapathy, V., Thangaraju, M., Gopal, E., Martin, P.M., Itagaki, S., Miyauchi, S., Prasad, P.D., Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J. 10 (2008), 193–199, 10.1208/s12248-008-9022-y.
75. Gardian, G., Browne, S.E., Choi, D.-K., Klivenyi, P., Gregorio, J., Kubilus, J.K., Ryu, H., Langley, B., Ratan, R.R., Ferrante, R.J., Beal, M.F., Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J. Biol. Chem. 280 (2005), 556–563, 10.1074/jbc.M410210200.
76. Gaschott, T., Steinhilber, D., Milovic, V., Stein, J., Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells. J. Nutr. 131 (2001), 1839–1843.
77. Gerhart, D.Z., Enerson, B.E., Zhdankina, O.Y., Leino, R.L., Drewes, L.R., Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am. J. Physiol. 273 (1997), E207–E213.
78. Gilbert, K.M., DeLoose, A., Valentine, J.L., Fifer, E.K., Structure-activity relationship between carboxylic acids and T cell cycle blockade. Life Sci. 78 (2006), 2159–2165, 10.1016/j.lfs.2005.09.047.
79. Ginsburg, E., Salomon, D., Sreevalsan, T., Freese, E., Growth inhibition and morphological changes caused by lipophilic acids in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 70 (1973), 2457–2461.
80. Govindarajan, N., Agis-Balboa, R.C., Walter, J., Sananbenesi, F., Fischer, A., Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. J. Alzheimers Dis. JAD 26 (2011), 187–197, 10.3233/JAD-2011-110080.
81. Gupta, N., Martin, P.M., Prasad, P.D., Ganapathy, V., SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci. 78 (2006), 2419–2425, 10.1016/j.lfs.2005.10.028.
82. Guzmán, M., Blázquez, C., Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot. Essent. Fat. Acids 70 (2004), 287–292, 10.1016/j.plefa.2003.05.001.
83. Haapakoski, R., Ebmeier, K.P., Alenius, H., Kivimäki, M., Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances. Prog. Neuropsychopharmacol. Biol. Psychiatry 66 (2016), 63–72, 10.1016/j.pnpbp.2015.11.012.
84. Haettig, J., Stefanko, D.P., Multani, M.L., Figueroa, D.X., McQuown, S.C., Wood, M.A., HDAC inhibition modulates hippocampus-dependent long-term memory for object location in a CBP-dependent manner. Learn. Mem. 18 (2011), 71–79, 10.1101/lm.1986911.
85. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.-J., Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27 (2008), 104–119, 10.1111/j.1365-2036.2007.03562.x.
86. Havlicek, J., Roberts, S.C., MHC-correlated mate choice in humans: a review. Psychoneuroendocrinology 34 (2009), 497–512, 10.1016/j.psyneuen.2008.10.007.
87. Holt, R.J., The esterase and lipase activity of aerobic skin bacteria. Br. J. Dermatol. 85 (1971), 18–23.
88. Hurtubise, J.L., Howland, J.G., Effects of stress on behavioral flexibility in rodents. Neuroscience, 2016, 10.1016/j.neuroscience.2016.04.007.
89. Huuskonen, J., Suuronen, T., Nuutinen, T., Kyrylenko, S., Salminen, A., Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. Br. J. Pharmacol. 141 (2004), 874–880, 10.1038/sj.bjp.0705682.
90. Intlekofer, K.A., Berchtold, N.C., Malvaez, M., Carlos, A.J., McQuown, S.C., Cunningham, M.J., Wood, M.A., Cotman, C.W., Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 38 (2013), 2027–2034, 10.1038/npp.2013.104.
91. Iriki, T., Tamura, K., Ishii, M., Tanaka, H., Miyamoto, T., Onda, K., Concentrations of ketone body and antidiuretic hormone in cerebrospinal fluid in response to the intra-ruminal administration of butyrate in suckling calves. Anim. Sci. J. 80 (2009), 655–661, 10.1111/j.1740-0929.2009.00683.x.
92. Jakobsdottir, G., Jädert, C., Holm, L., Nyman, M.E., Propionic and butyric acids, formed in the caecum of rats fed highly fermentable dietary fibre, are reflected in portal and aortic serum. Br. J. Nutr. 110 (2013), 1565–1572, 10.1017/S0007114513000809.
93. Kalda, A., Heidmets, L.-T., Shen, H.-Y., Zharkovsky, A., Chen, J.-F., Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice. Behav. Brain Res. 181 (2007), 76–84, 10.1016/j.bbr.2007.03.027.
94. Karaki, S., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T., Furness, J.B., Kuwahara, A., Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res. 324 (2006), 353–360, 10.1007/s00441-005-0140-x.
95. Kekuda, R., Manoharan, P., Baseler, W., Sundaram, U., Monocarboxylate 4 mediated butyrate transport in a rat intestinal epithelial cell line. Dig. Dis. Sci. 58 (2013), 660–667, 10.1007/s10620-012-2407-x.
96. Kelly, J.R., Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Hyland, N.P., Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front. Cell. Neurosci., 9, 2015, 392, 10.3389/fncel.2015.00392.
97. Kien, C.L., Chang, J.C., Cooper, J.R., Butyric acid is synthesized by piglets. J. Nutr. 130 (2000), 234–237.
98. Kien, C.L., Peltier, C.P., Mandal, S., Davie, J.R., Blauwiekel, R., Effects of the in vivo supply of butyrate on histone acetylation of cecum in piglets. JPEN J. Parenter. Enter. Nutr. 32 (2008), 51–56.
99. Kim, C.H., Park, J., Kim, M., Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw. 14 (2014), 277–288, 10.4110/in.2014.14.6.277.
100. Kim, H.J., Leeds, P., Chuang, D.-M., The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J. Neurochem. 110 (2009), 1226–1240, 10.1111/j.1471-4159.2009.06212.x.
101. Kim, H.J., Rowe, M., Ren, M., Hong, J.-S., Chen, P.-S., Chuang, D.-M., Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J. Pharmacol. Exp. Ther. 321 (2007), 892–901, 10.1124/jpet.107.120188.
102. Kim, S.W., Hooker, J.M., Otto, N., Win, K., Muench, L., Shea, C., Carter, P., King, P., Reid, A.E., Volkow, N.D., Fowler, J.S., Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. Nucl. Med. Biol. 40 (2013), 912–918, 10.1016/j.nucmedbio.2013.06.007.
103. Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., Kobayashi, M., Hirasawa, A., Tsujimoto, G., Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl. Acad. Sci. 108 (2011), 8030–8035, 10.1073/pnas.1016088108.
104. Kläring, K., Hanske, L., Bui, N., Charrier, C., Blaut, M., Haller, D., Plugge, C.M., Clavel, T., Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. Int. J. Syst. Evol. Microbiol. 63 (2013), 4606–4612, 10.1099/ijs.0.051441-0.
105. Knowles, S.E., Jarrett, I.G., Filsell, O.H., Ballard, F.J., Production and utilization of acetate in mammals. Biochem. J. 142 (1974), 401–411, 10.1042/bj1420401.
106. Kratsman, N., Getselter, D., Elliott, E., Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model. Neuropharmacology 102 (2015), 136–145, 10.1016/j.neuropharm.2015.11.003.
107. Kumar, A., Choi, K.-H., Renthal, W., Tsankova, N.M., Theobald, D.E.H., Truong, H.-T., Russo, S.J., Laplant, Q., Sasaki, T.S., Whistler, K.N., Neve, R.L., Self, D.W., Nestler, E.J., Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48 (2005), 303–314, 10.1016/j.neuron.2005.09.023.
108. Lal, S., Kirkup, A.J., Brunsden, A.M., Thompson, D.G., Grundy, D., Vagal afferent responses to fatty acids of different chain length in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001), G907–G915.
109. Lattal, K.M., Barrett, R.M., Wood, M.A., Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav. Neurosci. 121 (2007), 1125–1131, 10.1037/0735-7044.121.5.1125.
110. Leder, A., Leder, P., Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5 (1975), 319–322, 10.1016/0092-8674(75)90107-5.
111. Lee, Y., Morrison, B.M., Li, Y., Lengacher, S., Farah, M.H., Hoffman, P.N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., Pellerin, L., Magistretti, P.J., Rothstein, J.D., Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487 (2012), 443–448, 10.1038/nature11314.
112. Levenson, J.M., O'Riordan, K.J., Brown, K.D., Trinh, M.A., Molfese, D.L., Sweatt, J.D., Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem. 279 (2004), 40545–40559, 10.1074/jbc.M402229200.
113. Levine, U.Y., Looft, T., Allen, H.K., Stanton, T.B., Butyrate-producing bacteria, including mucin degraders, from the swine intestinal tract. Appl. Environ. Microbiol. 79 (2013), 3879–3881, 10.1128/AEM.00589-13.
114. Li, C.-J., (eds.) Butyrate: Food Sources, Functions and Health Benefits, 2014, Nova Science Publishers, Inc, New York.
115. Li, R.W., Li, C.-J., Enhancing butyrate biosynthesis in the gut for health benefits. Li, C.-J., (eds.) Butyrate: Food Sources, Functions and Health Benefits, 2014, Nova Science Publishers, Inc, New York.
116. Liu, J., Sun, J., Wang, F., Yu, X., Ling, Z., Li, H., Zhang, H., Jin, J., Chen, W., Pang, M., Yu, J., He, Y., Xu, J., Neuroprotective effects of clostridium butyricum against vascular dementia in mice via metabolic butyrate. Biomed. Res. Int., 2015, 2015, e412946, 10.1155/2015/412946.
117. Li, W., Moallem, I., Paller, K.A., Gottfried, J.A., Subliminal smells can guide social preferences. Psychol. Sci. 18 (2007), 1044–1049, 10.1111/j.1467-9280.2007.02023.x.
118. Lombardo, M.P., Access to mutualistic endosymbiotic microbes: an underappreciated benefit of group living. Behav. Ecol. Sociobiol. 62 (2008), 479–497, 10.1007/s00265-007-0428-9.
119. López Soto, E.J., Gambino, L.O., Mustafá, E.R., Free fatty acid receptor 3 is a key target of short chain fatty acid. Channels 8 (2014), 169–171, 10.4161/chan.28956.
120. Louis, P., Duncan, S.H., McCrae, S.I., Millar, J., Jackson, M.S., Flint, H.J., Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J. Bacteriol. 186 (2004), 2099–2106.
121. Louis, P., Flint, H.J., Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294 (2009), 1–8, 10.1111/j.1574-6968.2009.01514.x.
122. Luo, Y., Jian, W., Stavreva, D., Fu, X., Hager, G., Bungert, J., Huang, S., Qiu, Y., Trans-regulation of histone deacetylase activities through acetylation. J. Biol. Chem. 284 (2009), 34901–34910, 10.1074/jbc.M109.038356.
123. Lyte, M., Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog., 9, 2013, e1003726, 10.1371/journal.ppat.1003726.
124. Macfabe, D.F., Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb. Ecol. Health Dis., 23, 2012, 10.3402/mehd.v23i0.19260.
125. MacFabe, D.F., Cain, D.P., Rodriguez-Capote, K., Franklin, A.E., Hoffman, J.E., Boon, F., Taylor, A.R., Kavaliers, M., Ossenkopp, K.-P., Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 176 (2007), 149–169, 10.1016/j.bbr.2006.07.025.
126. MacFabe, D.F., Cain, N.E., Boon, F., Ossenkopp, K.-P., Cain, D.P., Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav. Brain Res. 217 (2011), 47–54, 10.1016/j.bbr.2010.10.005.
127. Macfarlane, S., Macfarlane, G.T., Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 62 (2003), 67–72, 10.1079/PNS2002207.
128. Mariadason, J.M., Barkla, D.H., Gibson, P.R., Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. Am. J. Physiol. 272 (1997), G705–G712.
129. Mariadason, J.M., Catto-Smith, A., Gibson, P.R., Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats. Gut 44 (1999), 394–399.
130. Martin, P.M., Gopal, E., Ananth, S., Zhuang, L., Itagaki, S., Prasad, B.M., Smith, S.B., Prasad, P.D., Ganapathy, V., Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ketone bodies in the brain. J. Neurochem. 98 (2006), 279–288, 10.1111/j.1471-4159.2006.03878.x.
131. Mayer, E.A., Knight, R., Mazmanian, S.K., Cryan, J.F., Tillisch, K., Gut microbes and the brain: paradigm shift in neuroscience. J. Neurosci. Off. J. Soc. Neurosci. 34 (2014), 15490–15496, 10.1523/JNEUROSCI.3299-14.2014.
132. McKernan, D.P., Dennison, U., Gaszner, G., Cryan, J.F., Dinan, T.G., Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl. Psychiatry, 1, 2011, e36, 10.1038/tp.2011.37.
133. McOrist, A.L., Miller, R.B., Bird, A.R., Keogh, J.B., Noakes, M., Topping, D.L., Conlon, M.A., Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J. Nutr. 141 (2011), 883–889, 10.3945/jn.110.128504.
134. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16 (2016), 22–34, 10.1038/nri.2015.5.
135. Minamiyama, M., Katsuno, M., Adachi, H., Waza, M., Sang, C., Kobayashi, Y., Tanaka, F., Doyu, M., Inukai, A., Sobue, G., Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13 (2004), 1183–1192, 10.1093/hmg/ddh131.
136. Miyoshi, M., Sakaki, H., Usami, M., Iizuka, N., Shuno, K., Aoyama, M., Usami, Y., Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. Clin. Nutr. 30 (2011), 252–258, 10.1016/j.clnu.2010.09.012.
137. Montarolo, P.G., Goelet, P., Castellucci, V.F., Morgan, J., Kandel, E.R., Schacher, S., A critical period for macromolecular synthesis in long-term heterosynaptic facilitation in Aplysia. Science 234 (1986), 1249–1254.
138. Montiel-Castro, A.J., González-Cervantes, R.M., Bravo-Ruiseco, G., Pacheco-López, G., The microbiota–gut–brain axis: neurobehavioral correlates, health and sociality. Front. Integr. Neurosci., 7, 2013, 70, 10.3389/fnint.2013.00070.
139. Montiel-Castro, null, Augusto, J., Baez-Yanez, null, Mario, G., Pacheco-Lopez, G., Social neuroeconomics: the influence of microbiota in partner-choice and sociality. Curr. Pharm. Des. 20 (2014), 4774–4783.
140. Moreira, T.J.T.P., Pierre, K., Maekawa, F., Repond, C., Cebere, A., Liljequist, S., Pellerin, L., Enhanced cerebral expression of MCT1 and MCT2 in a rat ischemia model occurs in activated microglial cells. J. Cereb. Blood Flow. Metab. Off. J. Int. Soc. Cereb. Blood Flow. Metab. 29 (2009), 1273–1283, 10.1038/jcbfm.2009.50.
141. Müller-Schwarze, D., Müller-Schwarze, C., Singer, A.G., Silverstein, R.M., Mammalian pheromone: identification of active component in the subauricular scent of the male pronghorn. Science 183 (1974), 860–862, 10.1126/science.183.4127.860.
142. Nakamura, S., Kondo, N., Yamaguchi, Y., Hashiguchi, M., Tanabe, K., Ushiroda, C., Kawahashi-Tokuhisa, M., Yui, K., Miyakoda, M., Oku, T., Daily feeding of fructooligosaccharide or glucomannan delays onset of senescence in SAMP8 mice. Gastroenterol. Res. Pract., 2014, 2014, 303184, 10.1155/2014/303184.
143. Nandedkar, A.K., Kumar, S., Biosynthesis of fatty acids in mammary tissue. II. Synthesis of butyrate in lactating rabbit mammary supernatant fraction by the reversal of beta-oxidation. Arch. Biochem. Biophys. 134 (1969), 563–571.
144. Nandedkar, A.K., Schirmer, E.W., Pynadath, T.I., Kumar, S., Biosynthesis of fatty acids in mammary tissue. I. Purification and properties of fatty acid synthetase from lactating-goat mammary tissue. Arch. Biochem. Biophys. 134 (1969), 554–562.
145. Nilsson, N.E., Kotarsky, K., Owman, C., Olde, B., Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun. 303 (2003), 1047–1052.
146. Nøhr, M.K., Egerod, K.L., Christiansen, S.H., Gille, A., Offermanns, S., Schwartz, T.W., Møller, M., Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience 290 (2015), 126–137, 10.1016/j.neuroscience.2015.01.040.
147. Nøhr, M.K., Pedersen, M.H., Gille, A., Egerod, K.L., Engelstoft, M.S., Husted, A.S., Sichlau, R.M., Grunddal, K.V., Poulsen, S.S., Han, S., Jones, R.M., Offermanns, S., Schwartz, T.W., GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154 (2013), 3552–3564, 10.1210/en.2013-1142.
148. Norvell, A., McMahon, S.B., Rise of the rival. Science 327 (2010), 964–965, 10.1126/science.1187159.
149. Offermanns, S., Schwaninger, M., Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation. Trends Mol. Med. 21 (2015), 245–255, 10.1016/j.molmed.2015.02.002.
150. Ohata, A., Usami, M., Miyoshi, M., Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. Nutr. Burbank Los Angel. Cty. Calif. 21 (2005), 838–847, 10.1016/j.nut.2004.12.004.
151. Oldendorf, W.H., Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am. J. Physiol. 224 (1973), 1450–1453.
152. Overath, P., Sturm, T., Rammensee, H.-G., Of volatiles and peptides: in search for MHC-dependent olfactory signals in social communication. Cell. Mol. Life Sci. 71 (2014), 2429–2442, 10.1007/s00018-014-1559-6.
153. Parodi, B., Rossi, S., Morando, S., Cordano, C., Bragoni, A., Motta, C., Usai, C., Wipke, B.T., Scannevin, R.H., Mancardi, G.L., Centonze, D., Kerlero de Rosbo, N., Uccelli, A., Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathol. (Berl.) 130 (2015), 279–295, 10.1007/s00401-015-1422-3.
154. Payne, A.N., Chassard, C., Zimmermann, M., Müller, P., Stinca, S., Lacroix, C., The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr. Diabetes, 1, 2011, e12, 10.1038/nutd.2011.8.
155. Peleg, S., Feller, C., Forne, I., Schiller, E., Sévin, D.C., Schauer, T., Regnard, C., Straub, T., Prestel, M., Klima, C., Schmitt Nogueira, M., Becker, L., Klopstock, T., Sauer, U., Becker, P.B., Imhof, A., Ladurner, A.G., Life span extension by targeting a link between metabolism and histone acetylation in Drosophila. EMBO Rep. 17 (2016), 455–469, 10.15252/embr.201541132.
156. Pellerin, L., Bergersen, L.H., Halestrap, A.P., Pierre, K., Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J. Neurosci. Res. 79 (2005), 55–64, 10.1002/jnr.20307.
157. Pender, S.L., Quinn, J.J., Sanderson, I.R., MacDonald, T.T., Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000), G918–G924.
158. Peng, L., He, Z., Chen, W., Holzman, I.R., Lin, J., Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61 (2007), 37–41, 10.1203/01.pdr.0000250014.92242.f3.
159. Peng, L., Li, Z.-R., Green, R.S., Holzman, I.R., Lin, J., Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139 (2009), 1619–1625, 10.3945/jn.109.104638.
160. Peters, S.G., Pomare, E.W., Fisher, C.A., Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut 33 (1992), 1249–1252.
161. Pierre, K., Pellerin, L., Debernardi, R., Riederer, B.M., Magistretti, P.J., Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy. Neuroscience 100 (2000), 617–627.
162. Pluznick, J.L., Protzko, R.J., Gevorgyan, H., Peterlin, Z., Sipos, A., Han, J., Brunet, I., Wan, L.-X., Rey, F., Wang, T., Firestein, S.J., Yanagisawa, M., Gordon, J.I., Eichmann, A., Peti-Peterdi, J., Caplan, M.J., Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 4410–4415, 10.1073/pnas.1215927110.
163. Prasad, K.N., Sinha, P.K., Effect of sodium butyrate on mammalian cells in culture: a review. In Vitro 12 (1976), 125–132.
164. Prenderville, J.A., Kennedy, P.J., Dinan, T.G., Cryan, J.F., Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci. 38 (2015), 13–25.
165. Priori, D., Colombo, M., Clavenzani, P., Jansman, A.J.M., Lallès, J.-P., Trevisi, P., Bosi, P., The olfactory receptor OR51E1 is present along the gastrointestinal tract of pigs, co-localizes with enteroendocrine cells and is modulated by intestinal microbiota. PLoS One, 10, 2015, e0129501, 10.1371/journal.pone.0129501.
166. Pryde, S.E., Duncan, S.H., Hold, G.L., Stewart, C.S., Flint, H.J., The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217 (2002), 133–139, 10.1111/j.1574-6968.2002.tb11467.x.
167. Puddu, A., Sanguineti, R., Montecucco, F., Viviani, G.L., Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediat. Inflamm., 2014, 2014, 162021, 10.1155/2014/162021.
168. Rechkemmer, G., Rönnau, K., von Engelhardt, W., Fermentation of polysaccharides and absorption of short chain fatty acids in the mammalian hindgut. Comp. Biochem. Physiol. A 90 (1988), 563–568.
169. Redondo, R.L., Morris, R.G.M., Making memories last: the synaptic tagging and capture hypothesis. Nat. Rev. Neurosci. 12 (2011), 17–30, 10.1038/nrn2963.
170. Reigstad, C.S., Salmonson, C.E., Rainey, J.F., Szurszewski, J.H., Linden, D.R., Sonnenburg, J.L., Farrugia, G., Kashyap, P.C., Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 29 (2015), 1395–1403, 10.1096/fj.14-259598.
171. Reineccius, G., Heath, H.B., Flavor Chemistry and Technology. second ed., 2006, Taylor & Francis, Boca Raton.
172. Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., Pointner, A., Brath, H., Haslberger, A.G., Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537 (2014), 85–92, 10.1016/j.gene.2013.11.081.
173. Rezq, S., Abdel-Rahman, A.A., Central GPR109A activation mediates glutamate-dependent pressor response in conscious rats. J. Pharmacol. Exp. Ther. 356 (2016), 457–466, 10.1124/jpet.115.229146.
174. Rhee, S.H., Pothoulakis, C., Mayer, E.A., Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6 (2009), 306–314, 10.1038/nrgastro.2009.35.
175. Riggs, M.G., Whittaker, R.G., Neumann, J.R., Ingram, V.M., n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268 (1977), 462–464.
176. Rios-Covian, D., Gueimonde, M., Duncan, S.H., Flint, H.J., de los Reyes-Gavilan, C.G., Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol. Lett., 362, 2015, 10.1093/femsle/fnv176.
177. Rivière, A., Gagnon, M., Weckx, S., Roy, D., De Vuyst, L., Mutual cross-feeding interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 Explain the bifidogenic and butyrogenic effects of arabinoxylan oligosaccharides. Appl. Environ. Microbiol. 81 (2015), 7767–7781, 10.1128/AEM.02089-15.
178. Roullet, F.I., Lai, J.K.Y., Foster, J.A., In utero exposure to valproic acid and autism–a current review of clinical and animal studies. Neurotoxicol. Teratol. 36 (2013), 47–56, 10.1016/j.ntt.2013.01.004.
179. Roy, C.C., Kien, C.L., Bouthillier, L., Levy, E., Short-chain fatty acids: ready for prime time?. Nutr. Clin. Pract. Off. Publ. Am. Soc. Parenter. Enter. Nutr. 21 (2006), 351–366.
180. Ruff, J.S., Nelson, A.C., Kubinak, J.L., Potts, W.K., MHC signaling during social communication. Adv. Exp. Med. Biol. 738 (2012), 290–313, 10.1007/978-1-4614-1680-7_17.
181. Rumberger, J.M., Arch, J.R.S., Green, A., Butyrate and other short-chain fatty acids increase the rate of lipolysis in 3T3-L1 adipocytes. Peer J., 2, 2014, 10.7717/peerj.611.
182. Ryu, H., Smith, K., Camelo, S.I., Carreras, I., Lee, J., Iglesias, A.H., Dangond, F., Cormier, K.A., Cudkowicz, M.E., Brown, R.H., Ferrante, R.J., Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J. Neurochem. 93 (2005), 1087–1098, 10.1111/j.1471-4159.2005.03077.x.
183. Sampson, T.R., Mazmanian, S.K., Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17 (2015), 565–576, 10.1016/j.chom.2015.04.011.
184. Sanchis-Segura, C., Lopez-Atalaya, J.P., Barco, A., Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 34 (2009), 2642–2654, 10.1038/npp.2009.125.
185. Santos, P.S.C., Schinemann, J.A., Gabardo, J., Bicalho, M., da, G., New evidence that the MHC influences odor perception in humans: a study with 58 Southern Brazilian students. Horm. Behav. 47 (2005), 384–388, 10.1016/j.yhbeh.2004.11.005.
186. Sarna, G.S., Bradbury, M.W., Cremer, J.E., Lai, J.C., Teal, H.M., Brain metabolism and specific transport at the blood-brain barrier after portocaval anastomosis in the rat. Brain Res. 160 (1979), 69–83.
187. Schellinck, H.M., Brown, R.E., Slotnick, B.M., Training rats to discriminate between the odors of individual conspecifics. Anim. Learn. Behav. 19 (1991), 223–233, 10.3758/BF03197880.
188. Scheppach, W., Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group. Dig. Dis. Sci. 41 (1996), 2254–2259.
189. Schroeder, F.A., Lin, C.L., Crusio, W.E., Akbarian, S., Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 62 (2007), 55–64, 10.1016/j.biopsych.2006.06.036.
190. Schroeder, F.A., Penta, K.L., Matevossian, A., Jones, S.R., Konradi, C., Tapper, A.R., Akbarian, S., Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 33 (2008), 2981–2992, 10.1038/npp.2008.15.
191. Sealy, L., Chalkley, R., The effect of sodium butyrate on histone modification. Cell 14 (1978), 115–121, 10.1016/0092-8674(78)90306-9.
192. Selkrig, J., Wong, P., Zhang, X., Pettersson, S., Metabolic tinkering by the gut microbiome: implications for brain development and function. Gut Microbes 5 (2014), 0–1.
193. Sharma, S., Taliyan, R., Singh, S., Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity. Behav. Brain Res. 291 (2015), 306–314, 10.1016/j.bbr.2015.05.052.
194. Shen, H.-Y., Kalda, A., Yu, L., Ferrara, J., Zhu, J., Chen, J.-F., Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice. Neuroscience 157 (2008), 644–655, 10.1016/j.neuroscience.2008.09.019.
195. Shimazu, T., Hirschey, M.D., Huang, J.-Y., Ho, L.T.Y., Verdin, E., Acetate metabolism and aging: an emerging connection. Mech. Ageing Dev., 2010, 10.1016/j.mad.2010.05.001.
196. Shimazu, T., Hirschey, M.D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C.A., Lim, H., Saunders, L.R., Stevens, R.D., Newgard, C.B., Farese, R.V. Jr., de Cabo, R., Ulrich, S., Akassoglou, K., Verdin, E., Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339 (2013), 211–214, 10.1126/science.1227166.
197. Shin, H.J., Anzai, N., Enomoto, A., He, X., Kim, D.K., Endou, H., Kanai, Y., Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatol. Balt. Md 45 (2007), 1046–1055, 10.1002/hep.21596.
198. Siigur, U., Ormisson, A., Tamm, A., Faecal short-chain fatty acids in breast-fed and bottle-fed infants. Acta Paediatr. Oslo Nor. 1992:82 (1993), 536–538.
199. Singer, A.G., Beauchamp, G.K., Yamazaki, K., Volatile signals of the major histocompatibility complex in male mouse urine. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 2210–2214.
200. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P.D., Manicassamy, S., Munn, D.H., Lee, J.R., Offermanns, S., Ganapathy, V., Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139, 10.1016/j.immuni.2013.12.007.
201. Singh, P.B., Herbert, J., Roser, B., Arnott, L., Tucker, D.K., Brown, R.E., Rearing rats in a germ-free environment eliminates their odors of individuality. J. Chem. Ecol. 16 (1990), 1667–1682, 10.1007/BF01014099.
202. Sleeth, M.L., Thompson, E.L., Ford, H.E., Zac-Varghese, S.E.K., Frost, G., Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr. Res. Rev. 23 (2010), 135–145, 10.1017/S0954422410000089.
203. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science 341 (2013), 569–573, 10.1126/science.1241165.
204. Spange, S., Wagner, T., Heinzel, T., Krämer, O.H., Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell Biol. 41 (2009), 185–198, 10.1016/j.biocel.2008.08.027.
205. Stackebrandt, E., Kramer, I., Swiderski, J., Hippe, H., Phylogenetic basis for a taxonomic dissection of the genus Clostridium. FEMS Immunol. Med. Microbiol. 24 (1999), 253–258.
206. Stilling, R.M., Bordenstein, S.R., Dinan, T.G., Cryan, J.F., Friends with social benefits: host-microbe interactions as a driver of brain evolution and development?. Front. Cell. Infect. Microbiol., 4, 2014, 147, 10.3389/fcimb.2014.00147.
207. Stilling, R.M., Dinan, T.G., Cryan, J.F., Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav. 13 (2014), 69–86, 10.1111/gbb.12109.
208. Stilling, R.M., Fischer, A., The role of histone acetylation in age-associated memory impairment and Alzheimer's disease. Neurobiol. Learn. Mem. 96 (2011), 19–26, 10.1016/j.nlm.2011.04.002.
209. Sun, J., Ling, Z., Wang, F., Chen, W., Li, H., Jin, J., Zhang, H., Pang, M., Yu, J., Liu, J., Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis. Neurosci. Lett. 613 (2016), 30–35, 10.1016/j.neulet.2015.12.047.
210. Suzuki, T., Yoshida, S., Hara, H., Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr. 100 (2008), 297–305, 10.1017/S0007114508888733.
211. Sweatt, J.D., The emerging field of neuroepigenetics. Neuron 80 (2013), 624–632, 10.1016/j.neuron.2013.10.023.
212. Taggart, A.K.P., Kero, J., Gan, X., Cai, T.-Q., Cheng, K., Ippolito, M., Ren, N., Kaplan, R., Wu, K., Wu, T.-J., Jin, L., Liaw, C., Chen, R., Richman, J., Connolly, D., Offermanns, S., Wright, S.D., Waters, M.G., (D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem. 280 (2005), 26649–26652, 10.1074/jbc.C500213200.
213. Takahashi, K., Nishida, A., Fujimoto, T., Fujii, M., Shioya, M., Imaeda, H., Inatomi, O., Bamba, S., Andoh, A., Sugimoto, M., Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease. Digestion 93 (2016), 59–65, 10.1159/000441768.
214. Takuma, K., Hara, Y., Kataoka, S., Kawanai, T., Maeda, Y., Watanabe, R., Takano, E., Hayata-Takano, A., Hashimoto, H., Ago, Y., Matsuda, T., Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism. Pharmacol. Biochem. Behav. 126 (2014), 43–49, 10.1016/j.pbb.2014.08.013.
215. Tang, H., Lu, J.Y.-L., Zheng, X., Yang, Y., Reagan, J.D., The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist. Biochem. Biophys. Res. Commun. 375 (2008), 562–565, 10.1016/j.bbrc.2008.08.041.
216. Tarini, J., Wolever, T.M.S., The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl. Physiol. Nutr. Metab. 35 (2010), 9–16, 10.1139/H09-119.
217. Tazoe, H., Otomo, Y., Karaki, S.-I., Kato, I., Fukami, Y., Terasaki, M., Kuwahara, A., Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed. Res. Tokyo Jpn. 30 (2009), 149–156.
218. Thangaraju, M., Cresci, G.A., Liu, K., Ananth, S., Gnanaprakasam, J.P., Browning, D.D., Mellinger, J.D., Smith, S.B., Digby, G.J., Lambert, N.A., Prasad, P.D., Ganapathy, V., GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69 (2009), 2826–2832, 10.1158/0008-5472.CAN-08-4466.
219. Theis, K.R., Schmidt, T.M., Holekamp, K.E., Evidence for a bacterial mechanism for group-specific social odors among hyenas. Sci. Rep., 2, 2012, 10.1038/srep00615.
220. Theis, K.R., Venkataraman, A., Dycus, J.A., Koonter, K.D., Schmitt-Matzen, E.N., Wagner, A.P., Holekamp, K.E., Schmidt, T.M., Symbiotic bacteria appear to mediate hyena social odors. Proc. Natl. Acad. Sci. 110 (2013), 19832–19837, 10.1073/pnas.1306477110.
221. Thomas, R.H., Meeking, M.M., Mepham, J.R., Tichenoff, L., Possmayer, F., Liu, S., MacFabe, D.F., The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J. Neuroinflammation, 9, 2012, 153, 10.1186/1742-2094-9-153.
222. Titgemeyer, E.C., Mamedova, L.K., Spivey, K.S., Farney, J.K., Bradford, B.J., An unusual distribution of the niacin receptor in cattle. J. Dairy Sci. 94 (2011), 4962–4967, 10.3168/jds.2011-4193.
223. Topping, D.L., Clifton, P.M., Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81 (2001), 1031–1064.
224. Troyer, K., Microbes, herbivory and the evolution of social behavior. J. Theor. Biol. 106 (1984), 157–169.
225. Ulven, T., Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets. Front. Endocrinol., 3, 2012, 111, 10.3389/fendo.2012.00111.
226. Van den Abbeele, P., Belzer, C., Goossens, M., Kleerebezem, M., De Vos, W.M., Thas, O., De Weirdt, R., Kerckhof, F.-M., Van de Wiele, T., Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 7 (2013), 949–961, 10.1038/ismej.2012.158.
227. Vecsey, C.G., Hawk, J.D., Lattal, K.M., Stein, J.M., Fabian, S.A., Attner, M.A., Cabrera, S.M., McDonough, C.B., Brindle, P.K., Abel, T., Wood, M.A., Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation. J. Neurosci. 27 (2007), 6128–6140, 10.1523/JNEUROSCI.0296-07.2007.
228. Veiga, P., Pons, N., Agrawal, A., Oozeer, R., Guyonnet, D., Brazeilles, R., Faurie, J.-M., van Hylckama Vlieg, J.E.T., Houghton, L.A., Whorwell, P.J., Ehrlich, S.D., Kennedy, S.P., Changes of the human gut microbiome induced by a fermented milk product. Sci. Rep., 4, 2014, 6328, 10.1038/srep06328.
229. Verbeke, K.A., Boobis, A.R., Chiodini, A., Edwards, C.A., Franck, A., Kleerebezem, M., Nauta, A., Raes, J., van Tol, E.A.F., Tuohy, K.M., Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr. Res. Rev. 28 (2015), 42–66, 10.1017/S0954422415000037.
230. Vieira, E.L.M., Leonel, A.J., Sad, A.P., Beltrão, N.R.M., Costa, T.F., Ferreira, T.M.R., Gomes-Santos, A.C., Faria, A.M.C., Peluzio, M.C.G., Cara, D.C., Alvarez-Leite, J.I., Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J. Nutr. Biochem. 23 (2012), 430–436, 10.1016/j.jnutbio.2011.01.007.
231. Vijay, N., Morris, M.E., Role of monocarboxylate transporters in drug delivery to the brain. Curr. Pharm. Des. 20 (2014), 1487–1498.
232. Viosca, J., Jancic, D., López-Atalaya, J.P., Benito, E., Hunting for synaptic tagging and capture in memory formation. J. Neurosci. 27 (2007), 12761–12763, 10.1523/JNEUROSCI.4093-07.2007.
233. Vital, M., Howe, A.C., Tiedje, J.M., Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio, 5, 2014, e00889, 10.1128/mBio.00889-14.
234. Wakade, C., Chong, R., Bradley, E., Thomas, B., Morgan, J., Upregulation of GPR109A in Parkinson's disease. PLoS One, 9, 2014, e109818, 10.1371/journal.pone.0109818.
235. Walker, A.W., Duncan, S.H., McWilliam Leitch, E.C., Child, M.W., Flint, H.J., pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 71 (2005), 3692–3700, 10.1128/AEM.71.7.3692-3700.2005.
236. Wang, H.-B., Wang, P.-Y., Wang, X., Wan, Y.-L., Liu, Y.-C., Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig. Dis. Sci. 57 (2012), 3126–3135, 10.1007/s10620-012-2259-4.
237. Wedekind, C., Seebeck, T., Bettens, F., Paepke, A.J., MHC-dependent mate preferences in humans. Proc. Biol. Sci. 260 (1995), 245–249, 10.1098/rspb.1995.0087.
238. Wei, Y., Melas, P.A., Wegener, G., Mathé, A.A., Lavebratt, C., Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int. J. Neuropsychopharmacol. Off. Sci. J. Coll. Int. Neuropsychopharmacol. CINP, 18, 2015, 10.1093/ijnp/pyu032.
239. Won, Y.-J., Lu, V.B., Puhl, H.L., Ikeda, S.R., β-Hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3. J. Neurosci. Off. J. Soc. Neurosci. 33 (2013), 19314–19325, 10.1523/JNEUROSCI.3102-13.2013.
240. Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., Rane, S.G., Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J. Biol. Chem. 288 (2013), 25088–25097, 10.1074/jbc.M113.452516.
241. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Ismagilov, R.F., Mazmanian, S.K., Hsiao, E.Y., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276, 10.1016/j.cell.2015.02.047.
242. Yonezawa, T., Kurata, R., Yoshida, K., Murayama, M.A., Cui, X., Hasegawa, A., Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics. Curr. Med. Chem. 20 (2013), 3855–3871.
243. Yudkoff, M., Daikhin, Y., Nissim, I., Lazarow, A., Nissim, I., Brain amino acid metabolism and ketosis. J. Neurosci. Res. 66 (2001), 272–281.
244. Zarling, E.J., Ruchim, M.A., Protein origin of the volatile fatty acids isobutyrate and isovalerate in human stool. J. Lab. Clin. Med. 109 (1987), 566–570.
245. Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., Li, Y., Shi, J., An, W., Hancock, S.M., He, F., Qin, L., Chin, J., Yang, P., Chen, X., Lei, Q., Xiong, Y., Guan, K.-L., Regulation of cellular metabolism by protein lysine acetylation. Science 327 (2010), 1000–1004, 10.1126/science.1179689.
246. Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., Zhang, X., Yang, D., Yang, Y., Meng, H., Li, W., Melgiri, N.D., Licinio, J., Wei, H., Xie, P., Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol. Psychiatry., 2016, 10.1038/mp.2016.44.
247. Zimmerman, M.A., Singh, N., Martin, P.M., Thangaraju, M., Ganapathy, V., Waller, J.L., Shi, H., Robertson, K.D., Munn, D.H., Liu, K., Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am. J. Physiol. – Gastrointest. Liver Physiol. 302 (2012), G1405–G1415, 10.1152/ajpgi.00543.2011.
248. Zou, X.-H., Li, H.-M., Wang, S., Leski, M., Yao, Y.-C., Yang, X.-D., Huang, Q.-J., Chen, G.-Q., The effect of 3-hydroxybutyrate methyl ester on learning and memory in mice. Biomaterials 30 (2009), 1532–1541, 10.1016/j.biomaterials.2008.12.012.